News

Statins are advised for nearly everyone past a certain age, to reduce heart attacks. In future, weight loss jabs may become ...
In a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
Limited effectiveness, weight regain, and high prevalence of adverse events are the three key limitations of ...
The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.
A woman who lost 55 pounds on Ozempic opens up about the most difficult side effect she faced—and shares simple tips that ...
Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...
Mounjaro. Ozempic. Wegovy. Zepbound. All these are brand names linked in some way to diabetes and weight loss-or, as the ...
Tirzepatide conferred significantly greater weight loss than semaglutide at 72 weeks for adults with overweight or obesity, ...
Experts explain how to reverse facial volume loss caused by the side effect of Ozempic, from fillers to microneedling and fat ...
The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...
The effects they have on your body and mind vary, as Wegovy flips one appetite switch in your brain, while Mounjaro flips two ...
High-street pharmacies are ready to provide the jabs on the NHS and boost take-up for all, says senior pharmacist ...